CIP
THC icon

Chartwell Investment Partners’s Tenet Healthcare THC Stock Holding History

Chartwell Investment Partners’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$5.4M Buy
32,464
+15,428
+91% +$2.33M 0.19% 174
2024
Q2 		$2.27M Sell
17,036
-60,266
-78% -$7.25M 0.08% 273
2024
Q1 		$8.12M Sell
77,302
-30,918
-29% -$2.78M 0.28% 122
2023
Q4 		$8.18M Sell
108,220
-44,084
-29% -$2.79M 0.29% 125
2023
Q3 		$10M Sell
152,304
-20,465
-12% -$1.53M 0.39% 78
2023
Q2 		$14.1M Buy
172,769
+16,916
+11% +$1.2M 0.51% 42
2023
Q1 		$9.26M Buy
155,853
+25,452
+20% +$1.41M 0.35% 97
2022
Q4 		$6.36M Buy
130,401
+84,806
+186% +$3.92M 0.25% 145
2022
Q3 		$2.35M Buy
45,595
+1,604
+4% +$95.2K 0.1% 247
2022
Q2 		$2.31M Buy
43,991
+8,815
+25% +$613K 0.09% 259
2022
Q1 		$3.02M Buy
35,176
+1,470
+4% +$121K 0.1% 256
2021
Q4 		$2.75M Buy
33,706
+14,984
+80% +$1.1M 0.08% 270
2021
Q3 		$1.24M Buy
+18,722
New +$1.33M 0.04% 356

Other funds holding THC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Chartwell Investment Partners's THC Position: Q3 2024 in Review

Chartwell Investment Partners increased its Tenet Healthcare (THC) stake by 91% in Q3 2024, buying an estimated $2.33M and bringing the position to 32,464 shares worth $5.4M. The position accounts for 0.19% of the portfolio, ranked #174.

Chartwell Investment Partners first reported a position in THC in Q3 2021 and has held it in 13 quarters since. The position peaked at $14.1M in Q2 2023. 603 funds tracked by Wall St. Rank hold THC as of Q3 2024.

  • Chartwell Investment Partners held 32,464 shares of Tenet Healthcare worth $5.4M as of Q3 2024.
  • Chartwell Investment Partners bought 15,428 Tenet Healthcare shares in Q3 2024, an estimated $2.33M.
  • Tenet Healthcare made up 0.19% of Chartwell Investment Partners's portfolio in Q3 2024, its #174 holding.
  • Chartwell Investment Partners first reported a position in Tenet Healthcare in Q3 2021 and has held it in 13 quarters since.
  • Chartwell Investment Partners's Tenet Healthcare position peaked at $14.1M in Q2 2023.
  • 603 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2024.

Based on Chartwell Investment Partners's 13F filing for Q3 2024, filed 4 Nov 2024.